Skip to main content

Table 1 Baseline characteristics of PLWHA at the start of CPT on BMH before February 2012

From: Retrospective evaluation of cotrimoxazole use as preventive therapy in people living with HIV/AIDS in Boru Meda Hospital

Conditions Variables Number (%)
HIV infection clinical stage I 37 (14.92)
II 66 (26.61)
III 123 (49.60)
IV 22 (8.87)
Co morbid illness TB 29 (11.69)
Fungal infection 31 (12.75)
PCP 2 (0.8)
Others 18 (7.26)
Laboratory results CD4 count <350 cell/mm3 221 (89.11)
Hemoglobin <7 g/dl 4 (1.61)
Platelet count < 50,000 cells/dl 4 (1.61)
Neutrophil count < 750 cells/dl 3 (1.2)
  ALT > 115 IU/L (for males) >90 IU/L (for females) 3 (1.2)
  1. ALT- alanine transaminase, IU- international unit.